COVID-19

All articles by COVID-19

Mental health in the era of COVID and mass shootings
Mental health in the era of COVID and mass shootings
Jack O'Brien
May 25, 2022
3:02 pm

People are drained from the challenges of the world and healthcare organizations — and their marketing partners — must prioritize behavioral health needs.

Pfizer-BioNTech’s three-dose COVID vaccine effective in kids under 5
Pfizer-BioNTech’s three-dose COVID vaccine effective in kids under 5
Jack O'Brien
May 23, 2022
9:50 am

The companies are preparing to submit the appropriate documents to the Food and Drug Administration and the European Medical Authority for emergency use authorizations later this week.

Rite Aid, Bartell Drugs have COVID boosters available for kids between 5 and 11
Rite Aid, Bartell Drugs have COVID boosters available for kids between 5 and 11
Jack O'Brien
May 20, 2022
1:28 pm

The announcement came after the Centers for Disease Control and Prevention’s advisory committee voted to approve COVID vaccine boosters for kids in that age range.

Use of Pfizer, Merck antivirals rises in step with COVID case counts
Use of Pfizer, Merck antivirals rises in step with COVID case counts
Marc Iskowitz
May 19, 2022
9:31 am

Concurrent with the most recent wave of infections, providers are dispensing more of the antiviral pills, data show.

Five things for pharma marketers to know: Monday, May 16, 2022
Five things for pharma marketers to know: Monday, May 16, 2022
Jack O'Brien
May 16, 2022
5:00 am

How many lives could have been saved with COVID vaccinations?; Baby formula shortage benefits Abbott stock; Novavax eyes FDA approval for COVID vaccine in June.

Why ConnectRN is giving nurses the gifts they really want
Why ConnectRN is giving nurses the gifts they really want
Eric Berger
May 13, 2022
2:45 pm

The Nurses Weak Gifts campaign lets medical workers do a little venting.

Five things for pharma marketers to know: Friday, May 13, 2022
Five things for pharma marketers to know: Friday, May 13, 2022
Jack O'Brien
May 13, 2022
5:00 am

NIH licenses spike protein technology to WHO; Massachusetts pays $56 million to outbreak victims at veterans’ care center; Drug overdose deaths reach a new high.

5 takeaways from Johns Hopkins’ future-of-the-pandemic event
5 takeaways from Johns Hopkins’ future-of-the-pandemic event
Jack O'Brien
May 12, 2022
10:49 am

Rising case counts, an eventual shift to an endemic phase and more.

FDA refutes Bourla’s advice on 2nd course of Paxlovid
FDA refutes Bourla’s advice on 2nd course of Paxlovid
Marc Iskowitz
May 6, 2022
4:11 pm

The CEO’s suggestion for dealing with patients whose COVID symptoms relapse — taking a second course of the antiviral pill — is not supported by data, the agency said.

Awareness, use of anti-COVID drugs found low as access push begins
Awareness, use of anti-COVID drugs found low as access push begins
Marc Iskowitz
April 29, 2022
3:54 pm

Researchers say more public outreach is ‘urgently needed’ to raise awareness of the benefits of treatment.

  • From Our Partners